NCT02412917View on ClinicalTrials.gov

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

PHASE3TerminatedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
ShinglesHerpes ZosterPostherpetic Neuralgia
Interventions
DRUG

FV-100

antiviral nucleoside analog

DRUG

valacyclovir

antiviral nucleoside analog

Trial Locations (1)

77598

TX, Webster

Sponsors
All Listed Sponsors
lead

ContraVir Pharmaceuticals, Inc.

INDUSTRY